Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04614909
Title Phase 0/2 Study of Pamiparib in Newly Diagnosed and rGBM
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nader Sanai
Indications

glioblastoma

Therapies

Olaparib

Pamiparib

Pamiparib + Temozolomide

Olaparib + Pamiparib + Temozolomide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.